Preferential binding of 4-hydroxynonenal to lysine residues in specific parasite proteins in plakortin-treated Plasmodium falciparum-parasitized red blood cells by Keiling, Brigitte Evelin et al.
                             Elsevier Editorial System(tm) for Data in 
Brief 
                                  Manuscript Draft 
 
 
Manuscript Number: DIB-D-15-00436 
 
Title: Preferential binding of 4-hydroxynonenal to lysine residues in 
specific parasite proteins in plakortin-treated Plasmodium falciparum-
parasitized red blood cells  
 
Article Type: Data Article 
 
Keywords:  
 
Corresponding Author: Dr. Oleksii A Skorokhoda,  
 
Corresponding Author's Institution:  
 
First Author: Oleksii A Skorokhoda 
 
Order of Authors: Oleksii A Skorokhoda 
 
Abstract: The data show the frequencies by which the amino acid residues 
lysine, histidine and cysteine of six proteins of the malaria parasite 
Plasmodium falciparum are post-translationally modified by the 
lipoperoxydation endproduct 4-hydroxynonenal after challenging the 
parasitized red blood cell with plakortin. Plakortin is an antimalarial 
endoperoxide whose molecular anti-parasitic effect is described in [1]. 
The preference for lysine modifications is compared with other eukaryotic 
cells. Plakortin did not elicit hemoglobin leakage from host red blood 
cells and did not oxidize reduced glutathione 
 
Suggested Reviewers:  
 
Opposed Reviewers:  
 
 
1 
 
Data article: 
Preferential binding of 4-hydroxynonenal to lysine residues in specific parasite proteins in 
plakortin-treated Plasmodium falciparum-parasitized red blood cells 
Authors: 
Evelin Schwarzer
a
, Valentina Gallo
a
, Elena Valente
a
, Daniela Ulliers
a
, Orazio Taglialatela-
Scafati
b
, Paolo Arese
a
, Oleksii A Skorokhod
a
 
Affiliations: 
a
Department of Oncology, University of Torino, Via Santena 5bis, 10126 Torino, Italy 
b
Department of Pharmacy, University of Napoli “Federico II”, Via D. Montesano 49, 80131 
Napoli, Italy 
Contact email (corresponding author): olexii.skorokhod@unito.it (O.A. Skorokhod) 
Abstract 
The data show the frequencies by which the amino acid residues lysine, histidine and cysteine of 
six proteins of the malaria parasite Plasmodium falciparum are post-translationally modified by 
the lipoperoxydation endproduct 4-hydroxynonenal after challenging the parasitized red blood 
cell with plakortin. Plakortin is an antimalarial endoperoxide whose molecular anti-parasitic 
effect is described in [1]. The preference for lysine modifications is compared with other 
eukaryotic cells. Plakortin did not elicit hemoglobin leakage from host red blood cells and did 
not oxidize reduced glutathione.  
 
Specifications Table  
Subject area Biology  
More specific subject 
area 
Molecular pharmacology, antimalarial drug action, lipoperoxidation 
in malaria pathophysiology, proteomic assessment of post-
translational modifications   
Type of data Tables, graphs 
How data was acquired MALDI-TOF spectrometer (MALDI micro MX (Waters, Milford, 
MA, USA); Luminometer Sirius (Berthold, Pforzheim, Germany) 
Data format Processed data 
Experimental factors Parasitized and non-parasitized red blood cells were kept in in vitro 
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cell culture up to 24 h. Chemical extraction for parameter assessment.  
Experimental features Heme-dependent luminol-enhanced luminescence assay for  
hemoglobin. Thiol-reaction with DTNB and OD at 412 nm. Mass 
spectrometric analysis of peptides after trypsin-digestion of proteins. 
Data source location University of Torino, Torino, Italy 
Data accessibility Data are provided with this article and are related to [1] 
 
Value of the data 
•The data show how endoperoxide-elicited oxidative stress might specifically target parasite 
proteins of functional importance by binding the lipoperoxidation endproduct 4-HNE inducing 
parasite damage at still modest free radical concentration.  
•Data on endoperoxide-elicited modifications of proteins of a unicellular parasite as molecular 
cause for cell death may be of interest for similar studies with other microorganisms.  
•Data for lethal modifications of specific microbial proteins with lipoperoxidation endproducts 
such as 4-HNE may suggest a novel strategy for high throughput drug research, e.g. 
antimalarials.  
•The data on host red blood cells (RBC) intactness may be useful to monitor host cell damage by 
redox active substances. 
 
Data 
Frequencies of lysine residues modified by 4-HNE 
In Table 1 we list the numbers of lysine, histidine and cysteine residues (K, H and C 
respectively) that were found conjugated with 4-HNE and compare it with the total number of 
each of these amino acids in the respective protein. The complete list of 4-HNE modified 
plasmodium falciparum proteins detected after plakortin treated and specific sites of 
modification are reported in [1]. 
There is no particular imbalance between the portion of 4-HNE-conjugated amino acids in the 
proteins extracted from plakortin treated parasites. We note that Plasmodium proteins contain 
elevated % of asparagine and lysine residues [2], even more then in vertebrates, where K 
frequency is 2-3 times higher than that of H and C [3]. 
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Evidently, availability of the amino acid residue for 4-HNE is a crucial factor for binding. C 
residues engaged in disulfide bridges are no ligands for HNE, while the basic amino acid K 
might be more frequently exposed to the protein-solvent interface compared to H, and hence be 
more accessible to 4-HNE binding [4]. 
 
Table 1. Lysine (K), histidine (H) and cysteine (C) frequency in the primary structure of P. 
falciparum proteins. Uniprot: Universal Protein Resource, www.uniprot.org/; NCBI GI: The 
National Center for Biotechnology Information GenInfo Identifier, www.ncbi.nlm.nih.gov/; 
PlasmoDB: the Plasmodium genome resource, http://PlasmoDB.org. 
 4-HNE-MODIFIED PROTEIN (NAME, 
ALIAS; IDs) 
4-HNE BINDING  
SITES  
(distribution 
between K, H, C) 
K, H, C count  in the 
protein sequence and 
the total number of 
amino acids 
      
1 *HSP70-1, HSP70_PLAFA 
Uniprot: Q8IB24_PLAF7 
NCBI GI:124512406 
PlasmoDB: PF3D7_0818900 
K:17 
H:2 
C:2 
K:54 
H:7 
C:9 
Tot 680 AA 
    
2 *V-type proton ATPase catalytic subunit A 
(EC 3.6.3.14), vacuolar ATP synthase 
subunit a (vapA)  
Uniprot: Q76NM6, VATA_PLAF7;  
NCBI GI:124512982 
PlasmoDB: PF3D7_1311900 
K:2 
H:0 
C:0 
K:42 
H:6 
C:11 
Tot 611 AA 
    
3 *Enolase (EC 4.2.1.11)  
phosphopyruvate hydratase 
Uniprot: Q8IJN7, ENO_PLAF7; 
NCBI GI:124802328 
PlasmoDB: PF3D7_1015900 
K:10 
H:1 
C:1 
K:38 
H:4 
C:6 
Tot 446 AA 
    
4 *Vacuolar protein sorting-associated 
protein 11, putative, former RING finger 
protein PFE0100w,   
Uniprot: Q8I480-ZNRF2_PLAF7 
NCBI GI:124505963 
PlasmoDB: PF3D7_0502000 
K:13 
H:0 
C:0 
K:165 
H:31 
C:20 
Tot 1272 AA 
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5 
§
DYHC1_PLAF7; Dynein heavy chain-like 
protein,  
Uniprot: Q 8IBG1  
NCBI GI:296004907 
PlasmoDB:PF3D7_0729900 
K:0 
H:3 
C:0 
K:477 
H:79 
C:69 
Tot 4985 AA 
    
6 
§
Heat shock protein 70 (HSP70-2);  
BiP;GRP78 
Uniprot: Q8I2X4_PLAF7 
NCBI GI:124506906 
PlasmoDB:PF3D7_0917900 
K:4 
H:6 
C:2 
K:63 
H:6 
C:2 
Tot 652 AA 
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Table 2. Examples from the literature for 4-HNE binding site distribution between K, H, C 
in selected proteins. 
 4-HNE-MODIFIED 
PROTEIN (NAME, ALIAS; 
IDs) 
4-HNE BINDING 
SITE  
distribution 
between K, H, C 
K, H, C count in 
protein sequence and 
the number of all 
amino acids 
Reference 
       
1 Liver fatty acid-binding 
protein, L-FABR, P12710  
K:4 
H:1 
C:1 
K:17 
H:1 
C:1 
Tot 127 AA 
[5]  
2 Cytochrome c, P00004 K:10 
H:1 
C:0 
K:19 
H:3 
C:2 
Tot 105 AA 
[6]  
 Alpha-synuclein, SNCA, 
P37840 
 
K:2 
H:1 
C:0 
K:15 
H:1 
C:1 
Tot 140 AA 
[7]  
 
Data for hemoglobin release from RBC under plakortin treatment 
Culture of RBC infected with trophozoite-stage Plasmodium falciparum were treated with 0-10 
µM of plakortin and hemoglobin release was measured in culture supernatant (Figure 1). The 
concentration is indicated in nmol/l. The concentration in the whole RBC suspension was 1mM 
and assessed after complete lysis of RBCs in NaOH/Triton: this is the maximal achievable 
concentration of hemoglobin in the supernatant corresponding to 100% RBC-lysis. 
As shown in Figure 1 the hemoglobin is not released from RBC even under maximum applied 
concentration of 10 µM. Very low lysis is detectable in non-parasitized RBC (npRBC) and a still 
very modest, although double as high value in RBCs parasitized with mature forms of 
P.falciparum- the trophozoite. This elevated value in trophozoites depends on the parasite 
biology and plakortin independent. Plakortin has no effect on the barrier function of the host 
RBC irrespective whether parasitized or not.  
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Figure 1. Hemoglobin release from incubated trophozoite-stage cultures and npRBC 
measured as heme concentration in culture supernatant. A single point represent the mean of 
3 replicates of one experiment. N=3 independent experiments with 3 different blood donors. 
 
 
Reduced glutathione concentrations in RBC after plakortin treatment 
Reduced glutathione (GSH) was quantified in RBCs kept at 5% hematocrit in PBS supplemented 
with 20 mM glucose and plakortin for 24 h at 37°C. As presented in Figure 2 the GSH level in 
RBC remained unchanged  after plakortin supplementation in a wide concentration range from 1 
to 100 µM. 
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Fig. 2 Quantification of  reduced glutathione (GSH) in RBCs treated or not with plakortin 
(1-100 µM, final concentration). Columns present mean GSH ± SD values from 2 replicates 
performed with RBCs from two donors.  
 
Experimental Design, Materials and Methods 
Unless otherwise stated all materials were obtained from Sigma-Aldrich (St. Louis, MO, USA). 
Plakortin, methyl 4,8-diethyl-6-methyl-3,6-peroxy-9-dodecenoate, was obtained from the 
organic extract of the Caribbean sponge Plakortis simplex and purified by combination of 
column chromatography and HPLC as described [8]. The final purity of the compound was > 
99%. 
 
In vitro cultivation of Plasmodium falciparum and stage-specific enrichment of parasitized 
red blood cells 
Plasmodium falciparum (Palo Alto strain, Mycoplasma free) parasites were kept in permanent 
culture as described [9-11]. RBCs that were used for plakortin incubation experiments were from 
blood samples taken on the same day of the experiment. Cultures were incubated in a humidified 
CO2 cell incubator under a N2/CO2/O2 atmosphere of 90vol%:5vol%:5vol%. 
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Plakortin treatment of parasitized RBCs (pRBC) and npRBC. Pure plakortin was dissolved 
at 50 mM in ethanol (stock solution) and diluted to 10 mM with DMSO prior to use. The stock 
solution was kept at -20ºC until use. Synchronous cultures were supplemented with a single dose 
of 0-10 µM plakortin (final concentration) at trophozoite-stage (26-30 h post-invasion) and kept 
under standard culture conditions for 12-24 h until analysis. Enriched parasite fractions and 
npRBCs were treated similarly and kept under the same standard culture conditions. 
Hemoglobin quantification 
The hemoglobin concentration in the culture supernatant was assayed by heme-dependent 
luminol-enhanced luminescence. Luminescence was measured in a double-injector luminometer 
(Sirius; Berthold, Pforzheim, Germany) as described [12-14]. All assays were performed in 
triplicate. 
 
Preparation of protein extracts from pRBC 
Washed and 1700g sedimented npRBCs or pRBCs were hypo-osmotically lysed in a 10–fold 
excess (v/v) of ice-cold lysis buffer (10mM K2HPO4/KH2PO4 (pH 8.0), supplemented with a 
protease inhibitor cocktail containing: 1 mM EDTA, 250 µM phenyl-methyl-sulfonyl fluoride 
(PMSF), 1nM leupeptine, 3 µM pepstatine, the phosphatase inhibitors sodium orthovanadate and 
sodium fluoride at 1 mM, each and 100 µM Trolox, during 5 min on ice. The ruptured 
membranes and organelles of parasite origin were sedimented at 16,200g for 3 min at 4°C and 
the supernatant was discarded. The pellet was washed 10 times by resuspension in fresh lysis 
buffer and subsequent sedimentation at 16,200g for 1 min. pRBC preparations contained the host 
cell membrane as well as membranes and organelle debris from the parasite. The proteins were 
extracted with SDS-containing Laemmli buffer at 95°C for 5 min. Solubilized proteins were kept 
at -20°C prior to use and β-mercaptoethanol (5% v/v) was added to protein samples before 
loading to the SDS-PAGE. The proteins were quantified using the Bio-Rad Protein Assay (Bio-
Rad, Hercules, CA, USA). 
 
Identification of 4-HNE modified proteins by mass spectrometric analysis and peptide mass 
fingerprinting  
For the identification of 4-HNE-conjugated proteins in plakortin-treated parasites matrix assisted 
laser desorption ionization-time of flight (MALDI-TOF) mass spectrometric analysis was 
performed. Proteins extracted from enriched ring and trophozoite stage pRBCs and npRBCs 
cultured with or without 10 µM plakortin for 3h were separated by SDS-PAGE. Gels were 
stained with colloidal Coomassie, protein bands of interest excised from the gel and in-gel 
trypsin digested. MS analysis was performed on a MALDI-TOF spectrometer (MALDI micro 
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MX; Waters, Milford, MA) equipped with a delayed extraction unit, according to the tuning 
procedures suggested by the manufacturer, operating in reflectron mode [15, 16]. Peak lists were 
generated by Protein Lynx Global Server (Waters, Milford, MA). The 25 most intense masses 
were used for database searches against the SwissProt (Uniprot) and NCBI databases using the 
free search program MASCOT (http://www.matrixscience.com). The parameters used for the 
searches were: taxa Plasmodium falciparum, trypsin digestion, 1 missed cleavage, methionine 
oxidation and 4-HNE as variable modifications with a maximum error allowed of 100 ppm. For 
Plasmodium falciparum, proteins taken on to consideration had a Mascot score higher than 37 
for SwissProt searches and higher than 67 for NCBI searches, as suggested by Mascot to be 
“significant”. 
GSH assay in RBCs 
Assay of GSH in RBCs was performed according to [17]. GSH values were given as mM 
(μmol/ml packed RBCs). 
Statistical analysis 
Non-parametric Mann-Whitney U Test was used to determine the significance of difference 
between the groups’ means (PASW Statistics 18, SPSS IBM, Chicago, IL).  
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